Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Milagritos D. Tapia, Samba O. Sow, Kirsten E. Lyke et al. · The Lancet Infectious Diseases · 2015 · 216 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

Mieke Sprangers, Wandena Lakhai, Wouter Koudstaal et al. · Journal of Clinical Microbiology · 2003 · 188 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Olga De Santis, R Audran, Emilie Pothin et al. · The Lancet Infectious Diseases · 2015 · 152 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14